Abstracts

COVID-19 IN CHILDREN: WORSENING OUTCOMES DURING DELTA VARIANT WAVE

Pediatric cases of COVID-19 surged in the summer/fall of 2021 coinciding with the SARS-CoV-2 Delta variant. It is unclear whether the Delta variant caused more severe illness among pediatric patients. We leveraged the Children and COVID-19 in Colorado database to determine whether differences exist in demographics, underlying comorbidities, and outcomes among children requiring hospital admission…

PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE VERTICALLY HIV-INFECTED YOUTHS

The prevalence of subclinical liver abnormalities is high among people living with HIV, but data regarding perinatally HIV-infected children and adolescents (PHIV) are scarce. Non-invasive image techniques offer an opportunity to address non-alcoholic fatty liver disease (NAFLD) in a population in which the scores validated for adults have not been tested. Prospective transversal study including…

WEIGHT GAIN AMONG ADOLESCENTS ON DOLUTEGRAVIR: A REAL CONCERN?

Integrase Inhibitors (INI) are now the first-line treatment for people living with HIV, including children. Clinical trials among adults have risen concerns regarding weight gain in patients starting or switching to INI. Clinical trials in children and adolescents are ongoing, as there is concern regarding weight gain in this population, characterized by important changes in…